Mortality Risk Identification via Clinical Parameter Trajectory Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chronic hemodialysis patients experience a significantly higher mortality rate compared to the general population, necessitating an improved method to identify patients at increased risk of death to enable timely diagnostic and therapeutic interventions.
Innovation Solution
A method that determines specific clinical and biochemical parameters such as serum bicarbonate, potassium, calcium, hemoglobin, and others, analyzing their rate of change over time to identify significant changes indicative of increased mortality risk, allowing for early therapeutic interventions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional cross-sectional baseline characteristics or time-dependent Cox regression models are used to assess mortality risk, then the analysis is simple to perform, but the ability to identify patients at increased risk of death in a timely manner is insufficient
Solution Approach 1:
The method performs preliminary analysis by continuously monitoring multiple clinical and biochemical parameters over time to identify patients at risk before critical events occur. By establishing baseline trajectories and detecting deviations early, the system enables preventive interventions rather than reactive treatments, thus reducing mortality while maintaining analytical simplicity.
Solution Approach 2:
The method implements feedback by continuously comparing current parameter values against historical trajectories and statistical models. When significant deviations are detected, the system generates alerts that trigger further diagnostic evaluation and potential therapeutic intervention, creating a closed-loop monitoring system that improves risk identification accuracy without requiring complex real-time analysis.
2Reliability
If multiple clinical and biochemical parameters are monitored continuously over time, then the ability to identify patients at increased risk of death improves, but the complexity of data collection and analysis increases
Solution Approach 1:
The method uses a multi-functional analytical framework that simultaneously evaluates multiple clinical and biochemical parameters using the same statistical trajectory analysis approach. This universal method processes diverse data types (serum bicarbonate, potassium, calcium, hemoglobin, phosphorus, neutrophil to lymphocyte ratio, enPCR, eKdrt/V, EPO resistance index, TSAT, ferritin, creatinine, platelet count, liver enzymes) through a unified model, improving prediction reliability while avoiding the need for separate complex analysis systems for each parameter.
Solution Approach 2:
The method focuses on detecting changes in parameter trajectories rather than absolute values. By analyzing the rate of change and patterns of deterioration across multiple parameters, the system identifies patients at risk based on dynamic trends. This approach transforms complex multi-parameter monitoring into a simpler problem of detecting significant deviations from established trajectories, thereby improving reliability without proportionally increasing system complexity.
3Ease of manufacture
If traditional epidemiologic studies use cross-sectional baseline characteristics, then the study design is straightforward, but the ability to detect changes in mortality risk over the dialysis course is limited
Solution Approach 1:
The method implements continuous monitoring of clinical and biochemical parameters throughout the dialysis course, capturing the dynamic evolution of mortality risk. Rather than relying on single time-point measurements, the system continuously updates parameter trajectories and compares them against established patterns, maintaining simplicity in study design while comprehensively capturing temporal changes in risk that cross-sectional studies miss.
Data Source
AI summary
The invention is directed to a method of identifying a patient undergoing periodic hemodialysis treatments at increased risk for death that includes determining at least one of the patient's clinical or biochemical parameters, consisting of serum bicarbonate concentration level, serum potassium concentration level, serum calcium concentration level, hemoglobin concentration level, serum phosphorus concentration level, neutrophil to lymphocyte ratio, equilibrated normalized protein catabolic rate (enPCR), equilibrated fractional clearance of total body water by dialysis and residual kidney function (eKdrt/V), EPO resistance index, transferrin saturation index, serum ferritin concentration level, serum creatinine concentration level, platelet count, Aspartat-Aminotransferase level, and Alanin-Aminotransferase level at periodic hemodialysis treatments, and identifying a patient as having an increased risk for death if the patient has a significant change in the rate of change of at least one of the patient's clinical or biochemical parameters. The invention is also directed to a method of identifying an increased mortality risk factor for a patient undergoing periodic hemodialysis treatment. The method includes analyzing data of deceased patients that were previously undergoing periodic hemodialysis treatments by performing a longitudinal analysis backwards in time of changes in a clinical or biochemical parameter the patients, and identifying a significant change in the rate of decline or the rate of increase in a clinical or biochemical parameter before death of the patients.